We are live on ! Find out more
MCM

Marathon Capital Management Portfolio holdings

AUM $494M
1-Year Est. Return 42.6%
This Fund
S&P 500
This Quarter Est. Return
+10.44%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$245M
AUM Growth
+$21.3M
Cap. Flow
+$3.16M
Cap. Flow %
1.29%
Top 10 Hldgs %
67.31%
Holding
121
New
11
Increased
28
Reduced
53
Closed
9

Top Buys

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$2.24M
2
CVS icon
CVS Health
CVS
+$2.2M
3
NOK icon
Nokia
NOK
+$2M
4
ROKU icon
Roku
ROKU
+$1.16M
5
TPIC
TPI Composites
TPIC
+$980K

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$2.65M
2
CRCM
CARE.COM, INC.
CRCM
+$2.02M
3
ORBC
ORBCOMM, Inc.
ORBC
+$765K
4
ENPH icon
Enphase Energy
ENPH
+$516K
5
ENZ
Enzo Biochem, Inc.
ENZ
+$404K

Sector Composition

Rank Sector Weight
1 Financials 56.13%
2 Technology 17.14%
3 Healthcare 6.89%
4 Energy 5.17%
5 Industrials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OIG
51
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$690K 0.28%
20,992
+1,014
+5% +$43.4K
GOOG icon
52
Alphabet (Google) Class C
GOOG
$4.35T
$647K 0.26%
11,980
– –
TTI icon
53
TETRA Technologies
TTI
$1.14B
$623K 0.25%
382,445
+84,495
+28% +$170K
SLB icon
54
SLB Ltd
SLB
$73.4B
$611K 0.25%
15,385
+1,325
+9% +$53.4K
NBR icon
55
Nabors Industries
NBR
$1.27B
$606K 0.25%
4,180
+260
+7% +$41.5K
HON icon
56
Honeywell
HON
$77.6B
$591K 0.24%
3,597
-27
-0.7% -$4.3K
HDSN
57
Hudson Technologies
HDSN
$252M
$582K 0.24%
677,105
-34,670
-5% -$55.1K
CTVA icon
58
Corteva
CTVA
$53.6B
$555K 0.23%
+18,770
New +$505K
KO icon
59
Coca-Cola
KO
$377B
$552K 0.23%
10,851
+712
+7% +$34.9K
BAC.PRL icon
60
Bank of America Series L
BAC.PRL
$3.96B
$548K 0.22%
400
-5
-1% -$6.65K
XOM icon
61
ExxonMobil
XOM
$640B
$536K 0.22%
7,000
+3
+0% +$232
MPC icon
62
Marathon Petroleum
MPC
$92B
$535K 0.22%
9,576
+1,850
+24% +$101K
BRK.B icon
63
Berkshire Hathaway Class B
BRK.B
$1.1T
$520K 0.21%
2,444
+184
+8% +$38.1K
ALL icon
64
Allstate
ALL
$68.5B
$509K 0.21%
5,012
-17
-0.3% -$1.66K
DWX icon
65
State Street SPDR S&P International Dividend ETF
DWX
$530M
$505K 0.21%
12,849
-675
-5% -$26.1K
PFE icon
66
Pfizer
PFE
$143B
$471K 0.19%
11,465
+52
+0.5% +$2.06K
BNY
67
Bank of New York Mellon
BNY
$106B
$470K 0.19%
10,650
-390
-4% -$18.3K
OKE icon
68
Oneok
OKE
$56.8B
$409K 0.17%
5,949
-50
-0.8% -$3.37K
NETI
69
DELISTED
Eneti Inc.
NETI
$406K 0.17%
1,735
– –
TCX icon
70
Tucows
TCX
$168M
$404K 0.16%
6,625
-1,000
-13% -$71.9K
SANM icon
71
Sanmina
SANM
$10.1B
$378K 0.15%
12,500
– –
ENB icon
72
Enbridge
ENB
$119B
$372K 0.15%
10,326
-50
-0.5% -$1.82K
SBUX icon
73
Starbucks
SBUX
$121B
$369K 0.15%
4,408
-25
-0.6% -$1.96K
MCD icon
74
McDonald's
MCD
$192B
$356K 0.15%
1,717
– –
NUAN
75
DELISTED
Nuance Communications, Inc.
NUAN
$349K 0.14%
25,295
-1,530
-6% -$22.6K
1 2
3
4 5

Similar funds

LI
Lafayette Investments Ashton, Maryland $494M AUM 11.42% 1-Year Est. Return
SAS
Stelac Advisory Services New York $494M AUM 23.25% 1-Year Est. Return
BFIC
Bedell Frazier Investment Counselling Walnut Creek, California $495M AUM 29.32% 1-Year Est. Return
FSA
Financial Sense Advisors San Diego, California $493M AUM 50.68% 1-Year Est. Return
TAM
Talaria Asset Management Melbourne, Australia $495M AUM 21.62% 1-Year Est. Return
CH
Canton Hathaway Providence, Rhode Island $496M AUM 14.21% 1-Year Est. Return
TAA
Turiya Advisors Asia Hong Kong $496M AUM 75.42% 1-Year Est. Return
CWM
Cranbrook Wealth Management Bloomfield Hills, Michigan $492M AUM 14.37% 1-Year Est. Return

Marathon Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Marathon Capital Management held 121 positions worth $245M, up 9.5% from $224M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Marathon Capital Management's Q2 2019 filing shows 11 new, 28 increased, 53 reduced and 9 closed positions. Its largest new stake was Myriad Genetics: 79,460 shares worth $2.21M. The largest sale was DuPont de Nemours, an estimated $2.65M.

By sector, the portfolio is most concentrated in Financials at 56% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.

  • Marathon Capital Management's largest Q2 2019 buy was Myriad Genetics: 79,460 shares worth $2.21M.
  • Marathon Capital Management added most to Nokia in Q2 2019, an estimated $2M increase.
  • Marathon Capital Management's biggest Q2 2019 reduction was ORBCOMM, Inc., cutting an estimated $765K.
  • Marathon Capital Management fully exited DuPont de Nemours in Q2 2019, selling an estimated $2.65M.
  • Marathon Capital Management's ten largest holdings make up 67% of its $245M portfolio in Q2 2019.
  • Marathon Capital Management opened 11 new positions and closed 9 in Q2 2019.
  • Marathon Capital Management's portfolio value rose 9.5% quarter-over-quarter to $245M.

Based on Marathon Capital Management's 13F filing for Q2 2019, filed 25 Jul 2019.